Jack P. Antel

Active 1979–2025

229
Papers
48,630
Citations
120
h-index
226
i10-index

Citations

Citations per year for Jack P. Antel1973: 1 citations1978: 2 citations1980: 4 citations1981: 2 citations1982: 6 citations1983: 10 citations1984: 6 citations1985: 18 citations1986: 12 citations1987: 15 citations1988: 32 citations1989: 17 citations1990: 23 citations1991: 31 citations1992: 34 citations1993: 37 citations1994: 60 citations1995: 107 citations1996: 121 citations1997: 112 citations1998: 211 citations1999: 270 citations2000: 284 citations2001: 291 citations2002: 316 citations2003: 300 citations2004: 273 citations2005: 358 citations2006: 299 citations2007: 312 citations2008: 303 citations2009: 322 citations2010: 358 citations2011: 400 citations2012: 316 citations2013: 343 citations2014: 358 citations2015: 436 citations2016: 405 citations2017: 521 citations2018: 584 citations2019: 1,572 citations2020: 1,975 citations2021: 2,120 citations2022: 1,863 citations2023: 1,328 citations2024: 1,796 citations2025: 1,064 citations2026: 26 citations1974–1977: no citations, so these years are not shown1979: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,139 citing papers, 27.4% of this breakdownChina: 2,020 citing papers, 9% of this breakdownGermany: 1,828 citing papers, 8.1% of this breakdownUnited Kingdom: 1,591 citing papers, 7.1% of this breakdownCanada: 1,288 citing papers, 5.7% of this breakdownItaly: 1,117 citing papers, 5% of this breakdownFrance: 714 citing papers, 3.2% of this breakdownNetherlands: 659 citing papers, 2.9% of this breakdownSwitzerland: 644 citing papers, 2.9% of this breakdownAustralia: 603 citing papers, 2.7% of this breakdownSpain: 543 citing papers, 2.4% of this breakdownJapan: 492 citing papers, 2.2% of this breakdown
0%27.4%Other 21.4%

Fields

  • Medicine39.2%
  • Neuroscience28%
  • Biochemistry, Genetics and Molecular Biology20.1%
  • Immunology and Microbiology10.3%
  • Engineering0.5%
  • Agricultural and Biological Sciences0.4%
  • Other1.5%

Topics

  • Neuroinflammation and Neurodegeneration Mechanisms10.8%
  • Multiple Sclerosis Research Studies7.2%
  • Immune cells in cancer4%
  • Neurogenesis and neuroplasticity mechanisms3.5%
  • Tryptophan and brain disorders2.5%
  • Alzheimer's disease research and treatments2.1%
  • Other69.9%

Coauthors

All papers

Open in search
  1. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2016 cited by 1,526

  2. Identification of a unique TGF-β–dependent molecular and functional signature in microglia

    Authors: , , , , , , , , , , , , , , , , , - Nature Neuroscience 2013 cited by 2,642

  3. iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Neuron 2017 cited by 1,174

  4. Microglial control of astrocytes in response to microbial metabolites

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature 2018 cited by 1,062

  5. Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Communications 2020 cited by 597

  6. Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Neuroscience 2019 cited by 526

  7. An updated histological classification system for multiple sclerosis lesions

    Authors: , , , , , - Acta Neuropathologica 2016 cited by 699

  8. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mihaela Bejinariu, Florian Then Bergh, Arnfin Bergmann, Evanthia Bernitsas, Achim Berthele, Virender Bhan, Felix Bischof, Randall J. Bjork, Gregg Blevins, Matthias Boehringer, Thomas Boerner, Robert Bonek, James D. Bowen, Allen C. Bowling, Alexey Boyко, Cavit Boz, Vera Bracknies, Stefan Braune, Vincenzo Brescia Morra, Bruno Brochet, Waldemar Brola, Paul Brownstone, M Brozman, Donald Brunet, Ioan Buraga, Margaret Burnett, Mathias Buttmann, Helmut Butzkueven, Jonathan Cahill, Jonathan Calkwood, William Camu, Mark Cascione, G. Castelnovo, Diego Centonze, João Cerqueira, Andrew Chan, Andrea Cimprichová, Stanley Cohan, Giancarlo Comi, Jill Ker Conway, Joanna A. Cooper, John R. Corboy, Jorge Correale, Brian Costell, David A. Cottrell, Patricia K. Coyle, Matthew Craner, Liying Cui, Luı́s Cunha, Anna Członkowska, Ana Silva, Joao de, de Sèze, Marc Debouverie, Jan Debruyne, D. Decoo, G. Defer, Tobias Derfuß, Norma Deri, Bhupesh Dihenia, Péter Diószeghy, Vladimír Donáth, Bénédicte Dubois, Martin Duddy, Pierre Duquette, Gilles Edan, Hüsnü Efendi, Stanton B. Elias, Peter Emrich, Bonaventura Casanova Estruch and 228 more - The Lancet 2018 cited by 925

  9. MAFG-driven astrocytes promote CNS inflammation

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature 2020 cited by 508

  10. B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

    Authors: , , , , , , , , , , , - New England Journal of Medicine 2008 cited by 2,399

  11. A Highly Efficient Human Pluripotent Stem Cell Microglia Model Displays a Neuronal-Co-culture-Specific Expression Profile and Inflammatory Response

    Authors: , , , , , , , , , , , , , - Stem Cell Reports 2017 cited by 636

  12. Barcoded viral tracing of single-cell interactions in central nervous system inflammation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francisco J. Quintana - Science 2021 cited by 283

  13. Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Caterina Bendotti, Eleonora Aronica, Carola I. Radulescu, Jia Hui Wong, Anna M. Barron, Amy M. Smith, Samuel J. Barnes, David W. Hampton, Paul van der Valk, Steven Jacobson, Owain W. Howell, David Baker, Markus Kipp, Hannes Kaddatz, Benjamin B. Tournier, P. Millet, Paul M. Matthews, Craig S. Moore, Sandra Amor, David R. Owen - Nature Communications 2023 cited by 182

  14. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis

    Authors: , , , , , - Brain 2008 cited by 854

  15. Environmental Control of Astrocyte Pathogenic Activities in CNS Inflammation

    Authors: , , , , , , , , , , , , , , , , , - Cell 2019 cited by 262

  16. Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation

    Authors: , , , , , , , , , , , , , , , - Nature Medicine 2014 cited by 478

  17. Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clark C. Chen, Changiz Geula, Raghu Kalluri, Tomasz Żal, Amy B. Heimberger - OncoImmunology 2017 cited by 365

  18. Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JCI Insight 2016 cited by 454

  19. Inflammation in multiple sclerosis: consequences for remyelination and disease progression

    Authors: , , - Nature Reviews Neurology 2023 cited by 115

  20. Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trial

    Authors: , , , , , , , , , , , , , - Annals of Neurology 2009 cited by 939

  21. Droplet-based forward genetic screening of astrocyte–microglia cross-talk

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francisco J. Quintana - Science 2023 cited by 117

  22. Metabolic Control of Astrocyte Pathogenic Activity via cPLA2-MAVS

    Authors: , , , , , , , , , , , , , , , , , , , , - Cell 2019 cited by 209

  23. The role of glial cells in multiple sclerosis disease progression

    Authors: , , , - Nature Reviews Neurology 2022 cited by 144

  24. Lesion stage-dependent causes for impaired remyelination in MS

    Authors: , , , , , , , , , - Acta Neuropathologica 2020 cited by 140